Adam Kautzner - 01 Jul 2026 Form 3 Insider Report for Cigna Group (CI)

Reporting relationship: Officer
Issuer ticker: CI
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 09 Jul 2026, 19:34:58 UTC
Source filing: View source filing
Reporting owner signature: Tyler Gratton, attorney-in-fact

Key filing fact

Adam Kautzner filed Form 3 for Cigna Group (CI) on 09 Jul 2026.

Key facts

This page summarizes Adam Kautzner's Form 3 filing for Cigna Group (CI).
0 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 09 Jul 2026, 19:34.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002142575 Primary reporting owner

Kautzner Adam

Relationship: Officer
Address: 900 COTTAGE GROVE RD, BLOOMFIELD
Signature: Tyler Gratton, attorney-in-fact
Signature date: 09 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,533
Date: 01 Jul 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 1,608
Exercise price: $183.44
Footnotes: F1

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 1,579
Exercise price: $192.02
Footnotes: F2

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 2,008
Exercise price: $213.80
Footnotes: F3

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 1,778
Exercise price: $227.02
Footnotes: F4

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 3,764
Exercise price: $294.61
Footnotes: F5

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 5,955
Exercise price: $336.48
Footnotes: F6

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 8,708
Exercise price: $305.86
Footnotes: F7

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock, $.01 Par Value
Underlying amount: 5,628
Exercise price: $287.55
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

This option vested in three equal annual installments beginning February 27, 2020.

Footnote F2

This option vested in three equal annual installments beginning February 26, 2021.

Footnote F3

This option vested in three equal annual installments beginning March 1, 2022.

Footnote F4

This option vested in three equal annual installments beginning March 1, 2023.

Footnote F5

This option vested in three equal annual installments beginning March 1, 2024.

Footnote F6

This option vests in three equal annual installments beginning March 1, 2025.

Footnote F7

This option vests in three equal annual installments beginning March 1, 2026.

Footnote F8

This option vests in three equal annual installments beginning March 1, 2027.

SEC remarks

Title - President, Evernorth Care Management & Express Scripts and EVP, Customer Personalization / EX-24 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .